Global Stomach Cancer Treatment Databank Market Report
The Stomach Cancer Treatment market was valued at $4,211.5 Million in 2022, and is projected to reach $10,511.7 Million by 2031 growing at a CAGR of 10.76% from 2023 to 2031. Targeted Therapy segment is expected to be the highest contributor to this market, with $2,319.0 Million in 2022, and is anticipated to reach $5,613.5 Million by 2031, registering a CAGR of 10.38%. Chemotherapy segment is anticipated to reach $777.5 Million by 2031 with the highest CAGR of 12.69%. Targeted Therapy and Immunotherapy segments collectively expected to account for about 93.7% share of the Stomach Cancer Treatment market in 2022, with the former constituting around 55.1% share. Chemotherapy and Immunotherapy segments are expected to witness significant growth rates at a CAGR of 12.69% and 10.94% respectively, during the forecast period. Presently, share of these two segments is estimated to be around 44.9% in the overall Stomach Cancer Treatment market in 2022, and is anticipated to reach 46.6% by 2031.
- 1. Global Stomach Cancer Treatment Market, By Treatment Type
- 1.1. Overview
- 1.2. Immunotherapy
- 1.2.1 Immunotherapy Market, By Region
- 1.2.1.1 North America Immunotherapy Market, By Country
- 1.2.1.2 Europe Immunotherapy Market, By Country
- 1.2.1.3 Asia-Pacific Immunotherapy Market, By Country
- 1.2.1.4 Rest of World Immunotherapy Market, By Country
- 1.3. Targeted Therapy
- 1.3.1 Targeted Therapy Market, By Region
- 1.3.1.1 North America Targeted Therapy Market, By Country
- 1.3.1.2 Europe Targeted Therapy Market, By Country
- 1.3.1.3 Asia-Pacific Targeted Therapy Market, By Country
- 1.3.1.4 Rest of World Targeted Therapy Market, By Country
- 1.4. Chemotherapy
- 1.4.1 Chemotherapy Market, By Region
- 1.4.1.1 North America Chemotherapy Market, By Country
- 1.4.1.2 Europe Chemotherapy Market, By Country
- 1.4.1.3 Asia-Pacific Chemotherapy Market, By Country
- 1.4.1.4 Rest of World Chemotherapy Market, By Country
- 2. Global Stomach Cancer Treatment Market, By Disease Indication
- 2.1. Overview
- 2.2. Gastric Cancer/Gastroesophageal Junction Cancer
- 2.2.1 Gastric Cancer/Gastroesophageal Junction Cancer Market, By Region
- 2.2.1.1 North America Gastric Cancer/Gastroesophageal Junction Cancer Market, By Country
- 2.2.1.2 Europe Gastric Cancer/Gastroesophageal Junction Cancer Market, By Country
- 2.2.1.3 Asia-Pacific Gastric Cancer/Gastroesophageal Junction Cancer Market, By Country
- 2.2.1.4 Rest of World Gastric Cancer/Gastroesophageal Junction Cancer Market, By Country
- 2.3. Gastrointestinal Stromal Tumors
- 2.3.1 Gastrointestinal Stromal Tumors Market, By Region
- 2.3.1.1 North America Gastrointestinal Stromal Tumors Market, By Country
- 2.3.1.2 Europe Gastrointestinal Stromal Tumors Market, By Country
- 2.3.1.3 Asia-Pacific Gastrointestinal Stromal Tumors Market, By Country
- 2.3.1.4 Rest of World Gastrointestinal Stromal Tumors Market, By Country
- 3. Global Stomach Cancer Treatment Market, By Route of Administration
- 3.1. Overview
- 3.2. Oral
- 3.2.1 Oral Market, By Region
- 3.2.1.1 North America Oral Market, By Country
- 3.2.1.2 Europe Oral Market, By Country
- 3.2.1.3 Asia-Pacific Oral Market, By Country
- 3.2.1.4 Rest of World Oral Market, By Country
- 3.3. Injectable
- 3.3.1 Injectable Market, By Region
- 3.3.1.1 North America Injectable Market, By Country
- 3.3.1.2 Europe Injectable Market, By Country
- 3.3.1.3 Asia-Pacific Injectable Market, By Country
- 3.3.1.4 Rest of World Injectable Market, By Country
- 4. Global Stomach Cancer Treatment Market, By Drug Class
- 4.1. Overview
- 4.2. PD-1/PD-L1 Inhibitors
- 4.2.1 PD-1/PD-L1 Inhibitors Market, By Region
- 4.2.1.1 North America PD-1/PD-L1 Inhibitors Market, By Country
- 4.2.1.2 Europe PD-1/PD-L1 Inhibitors Market, By Country
- 4.2.1.3 Asia-Pacific PD-1/PD-L1 Inhibitors Market, By Country
- 4.2.1.4 Rest of World PD-1/PD-L1 Inhibitors Market, By Country
- 4.3. HER2 Antagonists
- 4.3.1 HER2 Antagonists Market, By Region
- 4.3.1.1 North America HER2 Antagonists Market, By Country
- 4.3.1.2 Europe HER2 Antagonists Market, By Country
- 4.3.1.3 Asia-Pacific HER2 Antagonists Market, By Country
- 4.3.1.4 Rest of World HER2 Antagonists Market, By Country
- 4.4. VEGFR2 Antagonists
- 4.4.1 VEGFR2 Antagonists Market, By Region
- 4.4.1.1 North America VEGFR2 Antagonists Market, By Country
- 4.4.1.2 Europe VEGFR2 Antagonists Market, By Country
- 4.4.1.3 Asia-Pacific VEGFR2 Antagonists Market, By Country
- 4.4.1.4 Rest of World VEGFR2 Antagonists Market, By Country
- 4.5. Other Drug Classes
- 4.5.1 Other Drug Classes Market, By Region
- 4.5.1.1 North America Other Drug Classes Market, By Country
- 4.5.1.2 Europe Other Drug Classes Market, By Country
- 4.5.1.3 Asia-Pacific Other Drug Classes Market, By Country
- 4.5.1.4 Rest of World Other Drug Classes Market, By Country
- 5. Global Stomach Cancer Treatment Market, By Region
- 5.1. Overview
- 5.2. North America
- 5.2.1 North America Stomach Cancer Treatment Market, By Treatment Type
- 5.2.2 North America Stomach Cancer Treatment Market, By Disease Indication
- 5.2.3 North America Stomach Cancer Treatment Market, By Route of Administration
- 5.2.4 North America Stomach Cancer Treatment Market, By Drug Class
- 5.2.5 North America Stomach Cancer Treatment Market, By Country
- 5.2.5.1 U.S.
- 5.2.5.1.1 U.S. Stomach Cancer Treatment Market, By Treatment Type
- 5.2.5.1.2 U.S. Stomach Cancer Treatment Market, By Disease Indication
- 5.2.5.1.3 U.S. Stomach Cancer Treatment Market, By Route of Administration
- 5.2.5.1.4 U.S. Stomach Cancer Treatment Market, By Drug Class
- 5.2.5.2 Canada
- 5.2.5.2.1 Canada Stomach Cancer Treatment Market, By Treatment Type
- 5.2.5.2.2 Canada Stomach Cancer Treatment Market, By Disease Indication
- 5.2.5.2.3 Canada Stomach Cancer Treatment Market, By Route of Administration
- 5.2.5.2.4 Canada Stomach Cancer Treatment Market, By Drug Class
- 5.3. Europe
- 5.3.1 Europe Stomach Cancer Treatment Market, By Treatment Type
- 5.3.2 Europe Stomach Cancer Treatment Market, By Disease Indication
- 5.3.3 Europe Stomach Cancer Treatment Market, By Route of Administration
- 5.3.4 Europe Stomach Cancer Treatment Market, By Drug Class
- 5.3.5 Europe Stomach Cancer Treatment Market, By Country
- 5.3.5.1 Germany
- 5.3.5.1.1 Germany Stomach Cancer Treatment Market, By Treatment Type
- 5.3.5.1.2 Germany Stomach Cancer Treatment Market, By Disease Indication
- 5.3.5.1.3 Germany Stomach Cancer Treatment Market, By Route of Administration
- 5.3.5.1.4 Germany Stomach Cancer Treatment Market, By Drug Class
- 5.3.5.2 U.K.
- 5.3.5.2.1 U.K. Stomach Cancer Treatment Market, By Treatment Type
- 5.3.5.2.2 U.K. Stomach Cancer Treatment Market, By Disease Indication
- 5.3.5.2.3 U.K. Stomach Cancer Treatment Market, By Route of Administration
- 5.3.5.2.4 U.K. Stomach Cancer Treatment Market, By Drug Class
- 5.3.5.3 France
- 5.3.5.3.1 France Stomach Cancer Treatment Market, By Treatment Type
- 5.3.5.3.2 France Stomach Cancer Treatment Market, By Disease Indication
- 5.3.5.3.3 France Stomach Cancer Treatment Market, By Route of Administration
- 5.3.5.3.4 France Stomach Cancer Treatment Market, By Drug Class
- 5.3.5.4 Italy
- 5.3.5.4.1 Italy Stomach Cancer Treatment Market, By Treatment Type
- 5.3.5.4.2 Italy Stomach Cancer Treatment Market, By Disease Indication
- 5.3.5.4.3 Italy Stomach Cancer Treatment Market, By Route of Administration
- 5.3.5.4.4 Italy Stomach Cancer Treatment Market, By Drug Class
- 5.3.5.5 Spain
- 5.3.5.5.1 Spain Stomach Cancer Treatment Market, By Treatment Type
- 5.3.5.5.2 Spain Stomach Cancer Treatment Market, By Disease Indication
- 5.3.5.5.3 Spain Stomach Cancer Treatment Market, By Route of Administration
- 5.3.5.5.4 Spain Stomach Cancer Treatment Market, By Drug Class
- 5.3.5.6 Rest of Europe
- 5.3.5.6.1 Rest of Europe Stomach Cancer Treatment Market, By Treatment Type
- 5.3.5.6.2 Rest of Europe Stomach Cancer Treatment Market, By Disease Indication
- 5.3.5.6.3 Rest of Europe Stomach Cancer Treatment Market, By Route of Administration
- 5.3.5.6.4 Rest of Europe Stomach Cancer Treatment Market, By Drug Class
- 5.4. Asia-Pacific
- 5.4.1 Asia-Pacific Stomach Cancer Treatment Market, By Treatment Type
- 5.4.2 Asia-Pacific Stomach Cancer Treatment Market, By Disease Indication
- 5.4.3 Asia-Pacific Stomach Cancer Treatment Market, By Route of Administration
- 5.4.4 Asia-Pacific Stomach Cancer Treatment Market, By Drug Class
- 5.4.5 Asia-Pacific Stomach Cancer Treatment Market, By Country
- 5.4.5.1 China
- 5.4.5.1.1 China Stomach Cancer Treatment Market, By Treatment Type
- 5.4.5.1.2 China Stomach Cancer Treatment Market, By Disease Indication
- 5.4.5.1.3 China Stomach Cancer Treatment Market, By Route of Administration
- 5.4.5.1.4 China Stomach Cancer Treatment Market, By Drug Class
- 5.4.5.2 Japan
- 5.4.5.2.1 Japan Stomach Cancer Treatment Market, By Treatment Type
- 5.4.5.2.2 Japan Stomach Cancer Treatment Market, By Disease Indication
- 5.4.5.2.3 Japan Stomach Cancer Treatment Market, By Route of Administration
- 5.4.5.2.4 Japan Stomach Cancer Treatment Market, By Drug Class
- 5.4.5.3 South Korea
- 5.4.5.3.1 5.4.5.3.2
- South Korea Stomach Cancer Treatment Market, By Disease Indication 5.4.5.3.3
- South Korea Stomach Cancer Treatment Market, By Route of Administration 5.4.5.3.4
- South Korea Stomach Cancer Treatment Market, By Drug Class 5.4.5.4
- India 5.4.5.4.1
- India Stomach Cancer Treatment Market, By Treatment Type 5.4.5.4.2
- India Stomach Cancer Treatment Market, By Disease Indication 5.4.5.4.3
- India Stomach Cancer Treatment Market, By Route of Administration 5.4.5.4.4
- India Stomach Cancer Treatment Market, By Drug Class 5.4.5.5
- Singapore 5.4.5.5.1
- Singapore Stomach Cancer Treatment Market, By Treatment Type 5.4.5.5.2
- Singapore Stomach Cancer Treatment Market, By Disease Indication 5.4.5.5.3
- Singapore Stomach Cancer Treatment Market, By Route of Administration 5.4.5.5.4
- Singapore Stomach Cancer Treatment Market, By Drug Class 5.4.5.6
- Rest of Asia 5.4.5.6.1
- Rest of Asia Stomach Cancer Treatment Market, By Treatment Type 5.4.5.6.2
- Rest of Asia Stomach Cancer Treatment Market, By Disease Indication 5.4.5.6.3
- Rest of Asia Stomach Cancer Treatment Market, By Route of Administration 5.4.5.6.4
- Rest of Asia Stomach Cancer Treatment Market, By Drug Class 5.5.
- Rest of World 5.5.1
- Rest of World Stomach Cancer Treatment Market, By Treatment Type 5.5.2
- Rest of World Stomach Cancer Treatment Market, By Disease Indication 5.5.3
- Rest of World Stomach Cancer Treatment Market, By Route of Administration 5.5.4
- Rest of World Stomach Cancer Treatment Market, By Drug Class 5.5.5
- Rest of World Stomach Cancer Treatment Market, By Country 5.5.5.1
- Brazil 5.5.5.1.1
- Brazil Stomach Cancer Treatment Market, By Treatment Type 5.5.5.1.2
- Brazil Stomach Cancer Treatment Market, By Disease Indication 5.5.5.1.3
- Brazil Stomach Cancer Treatment Market, By Route of Administration 5.5.5.1.4
- Brazil Stomach Cancer Treatment Market, By Drug Class 5.5.5.2
- Mexico 5.5.5.2.1
- Mexico Stomach Cancer Treatment Market, By Treatment Type 5.5.5.2.2
- Mexico Stomach Cancer Treatment Market, By Disease Indication 5.5.5.2.3
- Mexico Stomach Cancer Treatment Market, By Route of Administration 5.5.5.2.4
- Mexico Stomach Cancer Treatment Market, By Drug Class 5.5.5.3
- South Africa 5.5.5.3.1
- South Africa Stomach Cancer Treatment Market, By Treatment Type 5.5.5.3.2
- South Africa Stomach Cancer Treatment Market, By Disease Indication 5.5.5.3.3
- South Africa Stomach Cancer Treatment Market, By Route of Administration 5.5.5.3.4
- South Africa Stomach Cancer Treatment Market, By Drug Class 5.5.5.4
- Australia 5.5.5.4.1
- Australia Stomach Cancer Treatment Market, By Treatment Type 5.5.5.4.2
- Australia Stomach Cancer Treatment Market, By Disease Indication 5.5.5.4.3
- Australia Stomach Cancer Treatment Market, By Route of Administration 5.5.5.4.4
- Australia Stomach Cancer Treatment Market, By Drug Class 5.5.5.5
- ROW Countries 5.5.5.5.1
- ROW Countries Stomach Cancer Treatment Market, By Treatment Type 5.5.5.5.2
- ROW Countries Stomach Cancer Treatment Market, By Disease Indication 5.5.5.5.3
- ROW Countries Stomach Cancer Treatment Market, By Route of Administration 5.5.5.5.4
- ROW Countries Stomach Cancer Treatment Market, By Drug Class ROW Countries Stomach Cancer Treatment Market Value, By Drug Class, 2022-2031, Million USDLIST OF TABLES
- TABLE 1. Global Stomach Cancer Treatment Market Value, By Treatment Type, 2022-2031, Million USD
- TABLE 2. Immunotherapy Market Value, By Region, 2022-2031, Million USD
- TABLE 3. North America Immunotherapy Market Value, By Country, 2022-2031, Million USD
- TABLE 4. Europe Immunotherapy Market Value, By Country, 2022-2031, Million USD
- TABLE 5. Asia-Pacific Immunotherapy Market Value, By Country, 2022-2031, Million USD
- TABLE 6. Rest of World Immunotherapy Market Value, By Country, 2022-2031, Million USD
- TABLE 7. Targeted Therapy Market Value, By Region, 2022-2031, Million USD
- TABLE 8. North America Targeted Therapy Market Value, By Country, 2022-2031, Million USD
- TABLE 9. Europe Targeted Therapy Market Value, By Country, 2022-2031, Million USD
- TABLE 10. Asia-Pacific Targeted Therapy Market Value, By Country, 2022-2031, Million USD
- TABLE 11. Rest of World Targeted Therapy Market Value, By Country, 2022-2031, Million USD
- TABLE 12. Chemotherapy Market Value, By Region, 2022-2031, Million USD
- TABLE 13. North America Chemotherapy Market Value, By Country, 2022-2031, Million USD
- TABLE 14. Europe Chemotherapy Market Value, By Country, 2022-2031, Million USD
- TABLE 15. Asia-Pacific Chemotherapy Market Value, By Country, 2022-2031, Million USD
- TABLE 16. Rest of World Chemotherapy Market Value, By Country, 2022-2031, Million USD
- TABLE 17. Global Stomach Cancer Treatment Market Value, By Disease Indication, 2022-2031, Million USD
- TABLE 18. Gastric Cancer/Gastroesophageal Junction Cancer Market Value, By Region, 2022-2031, Million USD
- TABLE 19. North America Gastric Cancer/Gastroesophageal Junction Cancer Market Value, By Country, 2022-2031, Million USD
- TABLE 20. Europe Gastric Cancer/Gastroesophageal Junction Cancer Market Value, By Country, 2022-2031, Million USD
- TABLE 21. Asia-Pacific Gastric Cancer/Gastroesophageal Junction Cancer Market Value, By Country, 2022-2031, Million USD
- TABLE 22. Rest of World Gastric Cancer/Gastroesophageal Junction Cancer Market Value, By Country, 2022-2031, Million USD
- TABLE 23. Gastrointestinal Stromal Tumors Market Value, By Region, 2022-2031, Million USD
- TABLE 24. North America Gastrointestinal Stromal Tumors Market Value, By Country, 2022-2031, Million USD
- TABLE 25. Europe Gastrointestinal Stromal Tumors Market Value, By Country, 2022-2031, Million USD
- TABLE 26. Asia-Pacific Gastrointestinal Stromal Tumors Market Value, By Country, 2022-2031, Million USD
- TABLE 27. Rest of World Gastrointestinal Stromal Tumors Market Value, By Country, 2022-2031, Million USD
- TABLE 28. Global Stomach Cancer Treatment Market Value, By Route of Administration, 2022-2031, Million USD
- TABLE 29. Oral Market Value, By Region, 2022-2031, Million USD
- TABLE 30. North America Oral Market Value, By Country, 2022-2031, Million USD
- TABLE 31. Europe Oral Market Value, By Country, 2022-2031, Million USD
- TABLE 32. Asia-Pacific Oral Market Value, By Country, 2022-2031, Million USD
- TABLE 33. Rest of World Oral Market Value, By Country, 2022-2031, Million USD
- TABLE 34. Injectable Market Value, By Region, 2022-2031, Million USD
- TABLE 35. North America Injectable Market Value, By Country, 2022-2031, Million USD
- TABLE 36. Europe Injectable Market Value, By Country, 2022-2031, Million USD
- TABLE 37. Asia-Pacific Injectable Market Value, By Country, 2022-2031, Million USD
- TABLE 38. Rest of World Injectable Market Value, By Country, 2022-2031, Million USD
- TABLE 39. Global Stomach Cancer Treatment Market Value, By Drug Class, 2022-2031, Million USD
- TABLE 40. PD-1/PD-L1 Inhibitors Market Value, By Region, 2022-2031, Million USD
- TABLE 41. North America PD-1/PD-L1 Inhibitors Market Value, By Country, 2022-2031, Million USD
- TABLE 42. Europe PD-1/PD-L1 Inhibitors Market Value, By Country, 2022-2031, Million USD
- TABLE 43. Asia-Pacific PD-1/PD-L1 Inhibitors Market Value, By Country, 2022-2031, Million USD
- TABLE 44. Rest of World PD-1/PD-L1 Inhibitors Market Value, By Country, 2022-2031, Million USD
- TABLE 45. HER2 Antagonists Market Value, By Region, 2022-2031, Million USD
- TABLE 46. North America HER2 Antagonists Market Value, By Country, 2022-2031, Million USD
- TABLE 47. Europe HER2 Antagonists Market Value, By Country, 2022-2031, Million USD
- TABLE 48. Asia-Pacific HER2 Antagonists Market Value, By Country, 2022-2031, Million USD
- TABLE 49. Rest of World HER2 Antagonists Market Value, By Country, 2022-2031, Million USD
- TABLE 50. VEGFR2 Antagonists Market Value, By Region, 2022-2031, Million USD
- TABLE 51. North America VEGFR2 Antagonists Market Value, By Country, 2022-2031, Million USD
- TABLE 52. Europe VEGFR2 Antagonists Market Value, By Country, 2022-2031, Million USD
- TABLE 53. Asia-Pacific VEGFR2 Antagonists Market Value, By Country, 2022-2031, Million USD
- TABLE 54. Rest of World VEGFR2 Antagonists Market Value, By Country, 2022-2031, Million USD
- TABLE 55. Other Drug Classes Market Value, By Region, 2022-2031, Million USD
- TABLE 56. North America Other Drug Classes Market Value, By Country, 2022-2031, Million USD
- TABLE 57. Europe Other Drug Classes Market Value, By Country, 2022-2031, Million USD
- TABLE 58. Asia-Pacific Other Drug Classes Market Value, By Country, 2022-2031, Million USD
- TABLE 59. Rest of World Other Drug Classes Market Value, By Country, 2022-2031, Million USD
- TABLE 60. Global Stomach Cancer Treatment Market Value, By Region, 2022-2031, Million USD
- TABLE 61. North America Stomach Cancer Treatment Market Value, By Treatment Type, 2022-2031, Million USD
- TABLE 62. North America Stomach Cancer Treatment Market Value, By Disease Indication, 2022-2031, Million USD
- TABLE 63. North America Stomach Cancer Treatment Market Value, By Route of Administration, 2022-2031, Million USD
- TABLE 64. North America Stomach Cancer Treatment Market Value, By Drug Class, 2022-2031, Million USD
- TABLE 65. North America Stomach Cancer Treatment Market Value, By Country, 2022-2031, Million USD
- TABLE 66. U.S. Stomach Cancer Treatment Market Value, By Treatment Type, 2022-2031, Million USD
- TABLE 67. U.S. Stomach Cancer Treatment Market Value, By Disease Indication, 2022-2031, Million USD
- TABLE 68. U.S. Stomach Cancer Treatment Market Value, By Route of Administration, 2022-2031, Million USD
- TABLE 69. U.S. Stomach Cancer Treatment Market Value, By Drug Class, 2022-2031, Million USD
- TABLE 70. Canada Stomach Cancer Treatment Market Value, By Treatment Type, 2022-2031, Million USD
- TABLE 71. Canada Stomach Cancer Treatment Market Value, By Disease Indication, 2022-2031, Million USD
- TABLE 72. Canada Stomach Cancer Treatment Market Value, By Route of Administration, 2022-2031, Million USD
- TABLE 73. Canada Stomach Cancer Treatment Market Value, By Drug Class, 2022-2031, Million USD
- TABLE 74. Europe Stomach Cancer Treatment Market Value, By Treatment Type, 2022-2031, Million USD
- TABLE 75. Europe Stomach Cancer Treatment Market Value, By Disease Indication, 2022-2031, Million USD
- TABLE 76. Europe Stomach Cancer Treatment Market Value, By Route of Administration, 2022-2031, Million USD
- TABLE 77. Europe Stomach Cancer Treatment Market Value, By Drug Class, 2022-2031, Million USD
- TABLE 78. Europe Stomach Cancer Treatment Market Value, By Country, 2022-2031, Million USD
- TABLE 79. Germany Stomach Cancer Treatment Market Value, By Treatment Type, 2022-2031, Million USD
- TABLE 80. Germany Stomach Cancer Treatment Market Value, By Disease Indication, 2022-2031, Million USD
- TABLE 81. Germany Stomach Cancer Treatment Market Value, By Route of Administration, 2022-2031, Million USD
- TABLE 82. Germany Stomach Cancer Treatment Market Value, By Drug Class, 2022-2031, Million USD
- TABLE 83. U.K. Stomach Cancer Treatment Market Value, By Treatment Type, 2022-2031, Million USD
- TABLE 84. U.K. Stomach Cancer Treatment Market Value, By Disease Indication, 2022-2031, Million USD
- TABLE 85. U.K. Stomach Cancer Treatment Market Value, By Route of Administration, 2022-2031, Million USD
- TABLE 86. U.K. Stomach Cancer Treatment Market Value, By Drug Class, 2022-2031, Million USD
- TABLE 87. France Stomach Cancer Treatment Market Value, By Treatment Type, 2022-2031, Million USD
- TABLE 88. France Stomach Cancer Treatment Market Value, By Disease Indication, 2022-2031, Million USD
- TABLE 89. France Stomach Cancer Treatment Market Value, By Route of Administration, 2022-2031, Million USD
- TABLE 90. France Stomach Cancer Treatment Market Value, By Drug Class, 2022-2031, Million USD
- TABLE 91. Italy Stomach Cancer Treatment Market Value, By Treatment Type, 2022-2031, Million USD
- TABLE 92. Italy Stomach Cancer Treatment Market Value, By Disease Indication, 2022-2031, Million USD
- TABLE 93. Italy Stomach Cancer Treatment Market Value, By Route of Administration, 2022-2031, Million USD
- TABLE 94. Italy Stomach Cancer Treatment Market Value, By Drug Class, 2022-2031, Million USD
- TABLE 95. Spain Stomach Cancer Treatment Market Value, By Treatment Type, 2022-2031, Million USD
- TABLE 96. Spain Stomach Cancer Treatment Market Value, By Disease Indication, 2022-2031, Million USD
- TABLE 97. Spain Stomach Cancer Treatment Market Value, By Route of Administration, 2022-2031, Million USD
- TABLE 98. Spain Stomach Cancer Treatment Market Value, By Drug Class, 2022-2031, Million USD
- TABLE 99. Rest of Europe Stomach Cancer Treatment Market Value, By Treatment Type, 2022-2031, Million USD
- TABLE 100. Rest of Europe Stomach Cancer Treatment Market Value, By Disease Indication, 2022-2031, Million USD
- TABLE 101. Rest of Europe Stomach Cancer Treatment Market Value, By Route of Administration, 2022-2031, Million USD
- TABLE 102. Rest of Europe Stomach Cancer Treatment Market Value, By Drug Class, 2022-2031, Million USD
- TABLE 103. Asia-Pacific Stomach Cancer Treatment Market Value, By Treatment Type, 2022-2031, Million USD
- TABLE 104. Asia-Pacific Stomach Cancer Treatment Market Value, By Disease Indication, 2022-2031, Million USD
- TABLE 105. Asia-Pacific Stomach Cancer Treatment Market Value, By Route of Administration, 2022-2031, Million USD
- TABLE 106. Asia-Pacific Stomach Cancer Treatment Market Value, By Drug Class, 2022-2031, Million USD
- TABLE 107. Asia-Pacific Stomach Cancer Treatment Market Value, By Country, 2022-2031, Million USD
- TABLE 108. China Stomach Cancer Treatment Market Value, By Treatment Type, 2022-2031, Million USD
- TABLE 109. China Stomach Cancer Treatment Market Value, By Disease Indication, 2022-2031, Million USD
- TABLE 110. China Stomach Cancer Treatment Market Value, By Route of Administration, 2022-2031, Million USD
- TABLE 111. China Stomach Cancer Treatment Market Value, By Drug Class, 2022-2031, Million USD
- TABLE 112. Japan Stomach Cancer Treatment Market Value, By Treatment Type, 2022-2031, Million USD
- TABLE 113. Japan Stomach Cancer Treatment Market Value, By Disease Indication, 2022-2031, Million USD
- TABLE 114. Japan Stomach Cancer Treatment Market Value, By Route of Administration, 2022-2031, Million USD
- TABLE 115. Japan Stomach Cancer Treatment Market Value, By Drug Class, 2022-2031, Million USD
- TABLE 116. South Korea Stomach Cancer Treatment Market Value, By Disease Indication, 2022-2031, Million USD
- TABLE 117. South Korea Stomach Cancer Treatment Market Value, By Route of Administration, 2022-2031, Million USD
- TABLE 118. South Korea Stomach Cancer Treatment Market Value, By Drug Class, 2022-2031, Million USD
- TABLE 119. India Stomach Cancer Treatment Market Value, By Treatment Type, 2022-2031, Million USD
- TABLE 120. India Stomach Cancer Treatment Market Value, By Disease Indication, 2022-2031, Million USD
- TABLE 121. India Stomach Cancer Treatment Market Value, By Route of Administration, 2022-2031, Million USD
- TABLE 122. India Stomach Cancer Treatment Market Value, By Drug Class, 2022-2031, Million USD
- TABLE 123. Singapore Stomach Cancer Treatment Market Value, By Treatment Type, 2022-2031, Million USD
- TABLE 124. Singapore Stomach Cancer Treatment Market Value, By Disease Indication, 2022-2031, Million USD
- TABLE 125. Singapore Stomach Cancer Treatment Market Value, By Route of Administration, 2022-2031, Million USD
- TABLE 126. Singapore Stomach Cancer Treatment Market Value, By Drug Class, 2022-2031, Million USD
- TABLE 127. Rest of Asia Stomach Cancer Treatment Market Value, By Treatment Type, 2022-2031, Million USD
- TABLE 128. Rest of Asia Stomach Cancer Treatment Market Value, By Disease Indication, 2022-2031, Million USD
- TABLE 129. Rest of Asia Stomach Cancer Treatment Market Value, By Route of Administration, 2022-2031, Million USD
- TABLE 130. Rest of Asia Stomach Cancer Treatment Market Value, By Drug Class, 2022-2031, Million USD
- TABLE 131. Rest of World Stomach Cancer Treatment Market Value, By Treatment Type, 2022-2031, Million USD
- TABLE 132. Rest of World Stomach Cancer Treatment Market Value, By Disease Indication, 2022-2031, Million USD
- TABLE 133. Rest of World Stomach Cancer Treatment Market Value, By Route of Administration, 2022-2031, Million USD
- TABLE 134. Rest of World Stomach Cancer Treatment Market Value, By Drug Class, 2022-2031, Million USD
- TABLE 135. Rest of World Stomach Cancer Treatment Market Value, By Country, 2022-2031, Million USD
- TABLE 136. Brazil Stomach Cancer Treatment Market Value, By Treatment Type, 2022-2031, Million USD
- TABLE 137. Brazil Stomach Cancer Treatment Market Value, By Disease Indication, 2022-2031, Million USD
- TABLE 138. Brazil Stomach Cancer Treatment Market Value, By Route of Administration, 2022-2031, Million USD
- TABLE 139. Brazil Stomach Cancer Treatment Market Value, By Drug Class, 2022-2031, Million USD
- TABLE 140. Mexico Stomach Cancer Treatment Market Value, By Treatment Type, 2022-2031, Million USD
- TABLE 141. Mexico Stomach Cancer Treatment Market Value, By Disease Indication, 2022-2031, Million USD
- TABLE 142. Mexico Stomach Cancer Treatment Market Value, By Route of Administration, 2022-2031, Million USD
- TABLE 143. Mexico Stomach Cancer Treatment Market Value, By Drug Class, 2022-2031, Million USD
- TABLE 144. South Africa Stomach Cancer Treatment Market Value, By Treatment Type, 2022-2031, Million USD
- TABLE 145. South Africa Stomach Cancer Treatment Market Value, By Disease Indication, 2022-2031, Million USD
- TABLE 146. South Africa Stomach Cancer Treatment Market Value, By Route of Administration, 2022-2031, Million USD
- TABLE 147. South Africa Stomach Cancer Treatment Market Value, By Drug Class, 2022-2031, Million USD
- TABLE 148. Australia Stomach Cancer Treatment Market Value, By Treatment Type, 2022-2031, Million USD
- TABLE 149. Australia Stomach Cancer Treatment Market Value, By Disease Indication, 2022-2031, Million USD
- TABLE 150. Australia Stomach Cancer Treatment Market Value, By Route of Administration, 2022-2031, Million USD
- TABLE 151. Australia Stomach Cancer Treatment Market Value, By Drug Class, 2022-2031, Million USD
- TABLE 152. ROW Countries Stomach Cancer Treatment Market Value, By Treatment Type, 2022-2031, Million USD
- TABLE 153. ROW Countries Stomach Cancer Treatment Market Value, By Disease Indication, 2022-2031, Million USD
- TABLE 154. ROW Countries Stomach Cancer Treatment Market Value, By Route of Administration, 2022-2031, Million USD
- TABLE 155. ROW Countries Stomach Cancer Treatment Market Value, By Drug Class, 2022-2031, Million USD
- ROW Countries Stomach Cancer Treatment Market Value, By Drug Class, 2022-2031, Million USD
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook